Development of new poly(ADP-ribose) polymerase (PARP) inhibitors in ovarian cancer: Quo Vadis?

Epithelial ovarian cancer (EOC) is the fifth leading cause of cancer mortality among women, potentially due to ineffectiveness of screening tests for early detection. Patients typically present with advanced disease at diagnosis, whereas, up to 80% relapse and the estimated median progression-free s...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:Ann Transl Med
Main Authors: Boussios, Stergios, Moschetta, Michele, Karihtala, Peeter, Samartzis, Eleftherios P., Sheriff, Matin, Pappas-Gogos, George, Ozturk, Mehmet Akif, Uccello, Mario, Karathanasi, Afroditi, Tringos, Michail, Rassy, Elie, Pavlidis, Nicholas
פורמט: Artigo
שפה:Inglês
יצא לאור: AME Publishing Company 2020
נושאים:
Review Article on Ovarian Cancer: State of the Art and Perspectives of Clinical Research
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC7812175/
https://ncbi.nlm.nih.gov/pubmed/33490218
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/atm.2020.03.156
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים